共 50 条
A brief overview of drug-induced liver damage
被引:0
|作者:
Roy, Soumyadip
[1
]
Shah, Zalak
[1
]
Chakraborthy, G. S.
[1
]
机构:
[1] Parul Univ, Parul Inst Pharm & Res, Dept Pharmacol, Vadodara, Gujarat, India
关键词:
Liver injury;
Drug;
Hypersensitivity;
Toxicity;
Serum biomarkers;
INDUCED HEPATOTOXICITY;
ORAL MEDICATIONS;
HEPATITIS-B;
CELL-DEATH;
INJURY;
KERATIN-18;
BIOMARKERS;
FAILURE;
RISK;
MECHANISMS;
D O I:
10.1186/s43162-024-00315-7
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Drug-induced liver injury (DILI) is a prevalent disorder that can be led on by almost all drug types. The majority of benign DILI cases become better after drug discontinuation. To stop the development of acute or chronic liver failure, it is crucial to identify and get rid of the offending substance as soon as feasible. DILI does not have any identified risk factors, but certain people may be more susceptible due to genetic vulnerability and previous liver disease. Some patients may exhibit indications of systemic hypersensitivity, even though the majority of patients have clinical symptoms that are the same as those of other liver illnesses. Rapid drug withdrawal and supportive care aimed at reducing uncomfortable symptoms comprise the treatment for drug- and herbal-induced liver damage.
引用
收藏
页数:8
相关论文